Indeed, CEACAM6 is part of a family that includes members which are used routinely in clinical pathology to assess tumor specimens and inform disease prognosis and treatment.67–69 CEACAM6 itself is deemed of potential value as a prognosis marker in different types of cancers.33,34,38,40,41 Notably, measuring blood CEACAM6 transcript abundance is considered of potential value for the early detection of colorectal cancer.14–16. The gene discussed is CEACAM6; the disease is colorectal cancer.